Dr. Weiss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 984-974-0000Fax+1 984-974-2607
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2007 - 2010
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2004 - 2007
- Yale School of MedicineClass of 2004
Certifications & Licensure
- NC State Medical License 2010 - 2025
- PA State Medical License 2007 - 2010
- MA State Medical License 2006 - 2009
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2012 Feb 01
- Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR) Start of enrollment: 2012 Dec 11
- Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery Start of enrollment: 2012 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 610 citationsAntitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib ...Laura Q.M. Chow, Robert I. Haddad, Shilpa Gupta, Amit Mahipal, Ranee Mehra
Journal of Clinical Oncology. 2016-09-19 - 45 citationsInfluence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma.Robert I Haddad, Tanguy Y Seiwert, Laura Q M Chow, Shilpa Gupta, Jared Weiss
Journal for Immunotherapy of Cancer. 2022-02-01 - 39 citationsA phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors.Ezra E.W. Cohen, Michael J. Pishvaian, Dale R. Shepard, Ding Wang, Jared Weiss
Journal for Immunotherapy of Cancer. 2019-12-04
Lectures
- Preliminary toxicity data from the combination of pembrolizumab and definitive-dose radiotherapy for locally advanced head and neck cancer with contraindication to cis...2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Postoperative Chemoradiation: Which Patients, Which Agents?2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
Press Mentions
- Warning on Use of Sotorasib After ICI in Lung CancerJune 1st, 2023
- Lung Cancer Symptoms in Non-Smokers Misdiagnosed with COVIDFebruary 14th, 2023
- Woman, 39, Had Cough Diagnosed as COVID-19 Pneumonia. It Was Lung CancerMay 18th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: